Two themes define the BioNetwork conferences: insightful content and insane networking! We know that your success depends on meeting with the right
people at the relevant target companies. That’s why we build in a ton of formal and information networking opportunities. Other conferences talk about it,
BioNetwork delivers it! |  Partnering Made Easy: One-On-One Meeting Rooms, available
throughout all 3 days of BioNetwork!Register for Bionetwork and our team will
grant you access to the 1.1 partnering
website when it goes live, the week of
August 24th. Once you receive your login
credentials, you may begin sending
meeting requests to other attendees and
launching successful partnerships. Note that meeting rooms are limited
and on a first come first served basis. Questions regarding the site may
be directed to Rachel Schwartz at rschwartz@wbresearch.com |  Cocktail Receptions At The Monarch Bay Courtyard at the Ritz
Carlton Hotel
There is no better way to cap the day of
back-to-back meetings and stimulating
panels and presentations than gathering
around the courtyard to enjoy food and
cocktails, and maybe even catching the sun
set with your peers. Don’t miss these two
cocktail receptions prepared exclusively for
BioNetwork attendees:
Monday, October 5 @ 5:00 p.m.
Sponsored by:
| | Tuesday, October 6 @ 5:10 p.m. |
|  Round Table Discussions: Tuesday, October 6, 2009 @ 1:55p.m.
Brainstorm with BD and IP practitioners
who are going through the same
challenges as you are and come together
through these round table sessions to find
practical answers and solutions.
Here’s how it works: Choose a table as soon as you register for the event
(go to www.bionetworkus.com). Each table will be led by a moderator
who will engage participants to raise key questions and help facilitate a
healthy idea exchange. The round table discussion will run for 50
minutes, followed by a refreshment break and will wrap up with each
moderator summarizing the important questions and key lessons
gathered during the discussion.
Table 1: M&A: Transition Planning Post-Deal, Post-Merger
Interactions/Integration, And Making The Deal Work For Both
Sides
Moderator: Daniel J. Curran, M.D., Vice President, Corporate
Development, Millennium: The Takeda Oncology Company
Table 2: Managing Project Timelines And Scope Changes:
What Are The Barriers For Both Parties?
Moderator: Michael Myers, Director Global External R&D
– Due Diligence, Eli Lilly & Co.
Table 3: Partnering With The Government: Gaining Better Access
To Government Funding Sources To Support Your Drug
Development Programs
Moderator: David Wurtman, SVP Corporate Development, NexBio |
|